Healthcare

Midlevel healthcare jobs more than doubled to 505,000 between 2010 and 2022.

The Food and Drug Administration approved its Optune Pax product, which delivers tumor treating fields, for certain pancreatic cancers.

AppLovin and Cisco slide after reporting earnings while Fastly soars on better-than-expected quarterly profit and solid guidance.

The medical device company posts weaker-than-expected quarterly earnings and issues dim guidance for 2026.

The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.

Robinhood reports weaker-than-expected growth in the fourth quarter while shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.

The Trump administration has started using AI to try to save money in Medicare. What it means for your coverage.

Humana shares are down more than 30% since the federal government announced plans last month to keep Medicare Advantage rates nearly flat in 2027.

Spotify posts significant gains in monthly active users, while CVS slips after earnings.

CVS Health earnings came in ahead of analyst forecasts but the company is concerned about Medicare rates.

Heightened regulatory scrutiny could be a major blow for the online drug retailer, which just shelved its plan for a Wegovy copycat.

Kyndryl’s chief financial officer, David Wyshner, departs the company amid a review of its accounting practices.

Lilly agrees to acquire Orna Therapeutics in an all-cash deal.

The initiative will offer discounted cash prices on about 40 drugs from the following manufacturers: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer.

The insurer issued a disappointing fourth-quarter earnings report.

Amazon shares tumble after the tech and online retailing giant forecasts $200 billion in capital expenditures for 2026.

Shares in the Danish drugmaker have tanked this week, dragged down by a weak sales outlook and the launch of a Wegovy knockoff.

Google parent Alphabet beats analysts’ expectations for quarterly earnings and revenue but its capital spending forecasts widely top estimates.

Bristol Myers Squibb issues an especially upbeat outlook for 2026, even as revenue is expected to fall within one product portfolio.

The pharmaceutical distributor and health services company raises its guidance for the second time.

Align, which makes the Invisalign teeth-straightening system, beat analysts’ estimates for quarterly earnings and revenue.

Trump-Xi detente continues, Fed’s Lisa Cook says inflation progress has stalled, Bitcoin falls below $70,000, and more news to start your day.

Advanced Micro Devices stock falls sharply even as the chip maker posts better-than-expected earnings and guidance.

GE HealthCare reported fourth-quarter earnings per share of $1.44 from sales of $5.7 billion. Wall Street was looking for earnings per share of $1.40 from sales of $5.6 billion.